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Abstract
We report an infant with localized pulmonary histoplasmosis in whom Histoplasma antibody 
assays, quantitative Histoplasma urine and serum antigen concentrations, and histopathologic 
findings of a mediastinal mass were nondiagnostic. A provisional diagnosis of histoplasmosis was 
established by using laboratory methods that increase the sensitivity of the antigen assay using 
ultrafiltration of urine and ethylenediaminetetraacetic acid/heat denaturation of serum proteins.
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Nonprogressive pulmonary histoplasmosis of infants is unusual and those affected often 
present with a mediastinal mass. Since neoplasm is a consideration, prompt diagnosis is 
essential. If seropositivity cannot be demonstrated, as commonly occurs in early infection 
and in progressively disseminating histoplasmosis, an invasive diagnostic procedure may be 
needed.1 Since histoplasmosis is uniformly associated with primary hematogenous 
dissemination that is limited by the development of an effective cellular immune response, 
sensitive and specific quantitative assays of Histoplasma antigen have been shown to provide 
strong diagnostic support early in infection.2 Recently, modification of the methodology to 
incorporate ultracentrifugation of urine samples, has been shown to substantially increase 
test sensitivity.3 Ethylenediaminetetraacetic acid (EDTA) denaturation of serum specimens 
improves the sensitivity for detection of antigenemia (Wheat LJ, submitted for publication). 
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We report a 5-month-old boy who presented with wheezing and was found to have a 
mediastinal mass. Histoplasmosis was suspected; however, antibody titers were 
nondiagnostic, but consistent with possible histoplasmosis; and standard Histoplasma 
antigen assays of serum and urine were negative. Urine and serum antigen were detected 
using urine ultrafiltration and heat denaturation of serum proteins. The diagnosis of 
histoplasmosis was later confirmed by antibody seroconversion.
CASE HISTORY
A 5-month-old previously well boy presented with increased work of breathing. His only 
previous illness had been an upper respiratory infection and possible bronchiolitis in the 
prior month. The family resided in Tennessee and the parents recalled that he had 
accompanied them on a hike in a state park. They reported no symptoms or illness in other 
family members.
On admission, his weight was 6.5 kg, respiratory rate was 65 breaths/min, heart rate was 
115/min, and blood pressure was 86/62 mm Hg. Oxygen saturation was 96% in room air. 
Examination revealed a tachypneic, nontoxic infant with prominent intercostal chest 
retractions. There was no lymphadenopathy, pallor, or facial puffiness. The trachea was in 
the midline. Pertinent physical findings were diminished air entry in the right chest, audible 
expiratory wheezing, and no audible crackles. The cardiac examination was normal and 
there was no hepatosplenomegaly. The balance of the physical examination was normal.
A complete blood count showed a hemoglobin of 9.7 g/dL, white blood cell count of 18,600 
cells/μL with 71% neutrophils, 25% lymphocytes, 2% monocytes, 1% eosinophils, 1% 
basophils, and a platelet count of 533,000/μL. The serum electrolytes were normal. Lactate 
dehydrogenase was 309 U/L. A chest radiograph showed deviation of the mediastinum to 
the left and hyperexpansion of the right middle and right lower lobes. There was no pleural 
effusion. Computerized tomography demonstrated a posterior mediastinal mass with an 
infiltrative process in the right upper lobe associated with right paratracheal and subcarinal 
lymphadenopathy. The carinal mass encased and compressed both the right main stem 
bronchus and right pulmonary artery. There was atelectasis of the right lower lobe. 
Bronchoscopy revealed external compression of the right mainstem bronchus. The 
differential diagnosis of the posterior and middle mediastinal mass included neurogenic 
tumors, lymphoma, teratoma, germ cell tumors, and infection, especially granulomatous 
infection due to histoplasmosis or tuberculosis. The tuberculin skin test was nonreactive and 
acid-fast bacilli were not seen in gastric aspirates. Histoplasma complement fixation (CF) 
titers to both yeast and mycelial antigens were nonreactive; Histoplasma immunodiffusion 
antibody titers demonstrated an M band. Standard Histoplasma antigen assays of both serum 
and urine were negative (MiraVista Diagnostics, Indianapolis, IN). Thereafter, an open 
biopsy of the subcarinal mass was performed and histopathologic findings included 
necrotizing granulomatous inflammation. Gomori methenamine silver, periodic acid-Schiff 
and acid-fast stains were negative and all cultures of the biopsy specimen were negative. 
HIV antibody was nonreactive. Since the diagnosis of histoplasmosis was still suspected, 
augmentation of the sensitivity of the Histoplasma antigen assay using ultrafiltration of urine 
and EDTA and heat denaturation of serum proteins was performed.
Srinivasan et al. Page 2






















Four milliliters of urine was centrifuged at 3656g for 16 minutes to yield a final volume of 
0.4 mL (10-fold concentration). Thereafter, the retentate was tested in the MVista 
Histoplasma antigen enzyme immunoassay (MV EIA).2 For quantitation, the antigen content 
of the assay calibrators was determined by comparison to reference standards containing 
known concentrations of Histoplasma capsulatum galactomannan. Samples with optical 
density values less than the cutoff for positivity were reported as “none detected.” 
Specimens with optical density readings that were greater than or equal to the cutoff for 
positivity, but that were less than the 0.6 ng/mL standard, were reported as “positive, <0.6 
ng/mL.” Antigen assay of serum was performed on a 300 μL sample which was treated with 
100 μL of EDTA at 104°C for 4 minutes. It was then tested in the MV EIA, as recommended 
in the Platelia Aspergillus antigen EIA.2
RESULTS
Results of the standard quantitative antigen assay performed on the nonconcentrated urine 
sample and the non-EDTA treated serum sample were negative. Repeat testing after 
ultracentrifugation of the urine specimen yielded a positive result, <0.6 ng/mL. The EDTA-
treated serum sample yielded a positive result of 2.11 ng/mL.
The patient was treated with itraconazole, 5 mg/kg/d administered orally for 10 weeks. 
Prednisone, 2 mg/kg/d was administered orally for 1 week followed by a 1 week taper. The 
patient was discharged after 6 days in no respiratory distress. At follow-up 6 weeks later, he 
was thriving and had no respiratory symptoms. A repeat Histoplasma CF test showed a titer 
of 1:128 to the yeast antigen, thereby confirming the diagnosis of histoplasmosis.
DISCUSSION
Histoplasmosis is caused by H. capsulatum, a dimorphic fungus found in large areas of the 
Ohio and Mississippi River Valleys. Infections are common in these regions and a sustained 
outbreak involving 100,000 cases has been reported.4 Infection results from inhalation of 
microconidia that become aerosolized when contaminated environmental sites are disturbed. 
Spores germinate in the lung where they undergo transformation to the parasitic yeast form. 
Ninety-five percent of infections are unrecognized or self-limited. Risk factors for more 
serious disease, often accompanied by progressive hematogenous fungal dissemination, 
include intense exposure, primary or acquired disorders of cellular immunity, and relative 
immaturity of immune function in otherwise normal infants.5
Localized infection associated with pulmonary infiltrates and hilar/mediastinal adenopathy 
is the most common presentation in symptomatic patients. However, localized pulmonary 
infection and bronchial compression during early infancy is rare.6 The only other reported 
case was that of an 18-month-old in whom computerized tomography of the chest showed a 
large, left mediastinal mass compressing the left, main-stem bronchus. Histologic 
examination of the nodes obtained by thoracotomy showed caseating granulomas with yeast 
forms typical of H. capsulatum.
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Although isolation of the organism from cultures provides the strongest confirmatory 
evidence for infection, cultures are negative in most patients with localized disease. Antigen 
detection is useful in making an early diagnosis of histoplasmosis before antibodies appear.7 
Using standard antigen methodology, the sensitivity of antigen detection is greater in urine 
than serum.8 In some cases, the antigen may be present in the urine below the assay’s 
detection limit. False-negative results are more likely in localized pulmonary histoplasmosis 
than in diffuse pulmonary or disseminated disease.9 Ultrafiltration could improve the 
sensitivity as shown by Egan et al3 Among 84 false-negative specimens, 62 (73.8%) were 
positive after ultrafiltration (P < 0.001) versus 2% of controls. Our patient had antigenuria 
below the detection limit of the standard quantitative MV EIA, which was positive at <0.6 
ng/mL after ultracentrifugation of the urine. The antigen was also not detected in the non-
EDTA treated serum specimen but was found to be positive at 2.11 ng/mL after EDTA 
treatment of the serum at 104°C. These results provided support for our decision to treat the 
patient for histoplasmosis. Demonstration of precipitin antibodies to the H. capsulatum M 
protein antigen further supported the diagnosis of histoplasmosis. The seroconversion of the 
yeast CF test on follow-up testing confirmed the diagnosis. The infant responded well to 
therapy with itraconazole. A brief course of prednisone was used to promptly relieve the 
bronchial obstruction caused by the subcarinal lymphadenitis.10 He remains well, 4 months 
after diagnosis. Further studies confirming the value of ultrafiltration and serum treatment 
are needed.
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